• Recardio halts UK heart trial on Brexit uncertainty pharmatimes
    October 11, 2018
    Medical research group Recardio has reportedly halted a trial of an experimental heart drug because of uncertainties surrounding the UK’s departure from the European Union.
PharmaSources Customer Service